Regeneus Hits the Fast Track with Major Japanese Partnership

Regeneus, an Australian regenerative medicine company, has entered into an collaboration with a major Japanese firm to manufacture its stem cell therapy Progenza, a move that may accelerate approval and that has a pair of analysts optimistic about the company’s future.

Read the full article by The Life Sciences Report here.